Friess Associates »

Catalyst Pharmaceutical Partners shares owned by Friess Associates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Friess Associates from 13F filings

Historical chart of Friess Associates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Friess Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Friess Associates

Quarter filed Position value Share count Share price at filing
2022-06-30 $2.1M 305k 7.01
2022-03-31 $4.7M 572k 8.29

More positions owned by Friess Associates

Amphastar Pharmaceuticals (AMPH)
Acm Research (ACMR)
Stratasys (SSYS)
Kura Sushi Usa Inc cl a (KRUS)
Dhi (DHX)
Information Services (III)
Tecnoglass (TGLS)
Titan Machinery (TITN)
Caleres (CAL)
Assertio Holdings (ASRT)
Daseke (DSKE)
Catalyst Pharmaceutical Partners (CPRX)
Axogen (AXGN)
Napco Security Systems (NSSC)
Carriage Services (CSV)

View all positions for Friess Associates

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Charles Schwab Investment Management
Goldman Sachs Group
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners